← Leaderboards
Hongling Zhao
Albert Einstein College Of Medicine
$1,401,004
Attributed
$2,802,007
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $837K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,802,007 · 2
By mechanism
R01$2,802,007 · 2
Top collaborators
- Edward L Schwartz8 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Evripidis Gavathiotis$9,805,575
- Yiyu Zou$1,384,420
- Chandan Guha$30,646,840
- Praveen Agrawal$583,200
- Bhaskar Chandra Das$3,457,971
Others in their field
Other Emerging Leaders on “Retinoblastoma Protein”
- Ramon Velazquez · Arizona State University-Tempe Campus$2,885,436
- Michael S. Kareta · Sanford Research/Usd$2,786,276
- Iain Morgan · Virginia Commonwealth University$2,779,718
- Gustavo A Nader · Pennsylvania State University, The$2,039,077
- Patrick Viatour · Children'S Hosp Of Philadelphia$1,914,803
- Gaspar Julius Kitange · Mayo Clinic Rochester$1,564,039
Research focus
Retinoblastoma ProteinTumorMouse ModelRb1 GeneThe Cancer Genome AtlasTreatment StrategyGeneticMediatingOncogenicProteinsTargeted TreatmentClinical TrialsTp53 GeneCancer PatientAffectEffective TherapyHuman ModelMalignant NeoplasmsMutationNeoplasm MetastasisOrganoidsPlayCombined Modality TherapyTumorigenesis
Grant awards (8)
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$155,403
R01 · FY2024 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$445,917
R01 · FY2023 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$83,068
R01 · FY2022 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$455,018
R01 · FY2021 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$455,018
R01 · FY2020 · CA
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis$382,013
R01 · FY2020 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53$455,018
R01 · FY2019 · CA
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis$370,552
R01 · FY2019 · CA